<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Amyloid <z:chebi fb="7" ids="16670">peptides</z:chebi> modulate cardiac calcium homoeostasis and play an important role in the pathophysiology of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Pulmonary veins (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PVs</z:e>) are critical in the genesis of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> and contain abundant amyloid <z:chebi fb="7" ids="16670">peptides</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, the purpose of this study is to investigate whether amyloid <z:chebi fb="7" ids="16670">peptides</z:chebi> may change the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> electrical activity through regulating calcium homoeostasis </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: The channel and calcium-handling protein expressions, intracellular calcium and ionic currents were studied in isolated rabbit <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> cardiomyocytes in the presence and absence (control) of beta-amyloid (Aβ(25-35) ) for 4-6 h, using Western blot analysis, <z:chebi fb="0" ids="52084">indo-1</z:chebi> fluorimetric ratio and whole-cell patch clamp techniques </plain></SENT>
<SENT sid="4" pm="."><plain>Aβ(25-35) decreased the expressions of Ca(V) 1.2, total or Ser16-phosphorylated phospholamban (p-PLB), p-PLB/PLB ratio, <z:chebi fb="199" ids="26708">sodium</z:chebi>/calcium exchanger, but did not change <z:chebi fb="0" ids="8925">ryanodine</z:chebi> receptor, sarcoplasmic reticulum (SR) ATPase and <z:chebi fb="0" ids="29103">K(+)</z:chebi> channel proteins (Kir2.1, Kir2.3, Kv1.4, Kv1.5 and Kv4.2) </plain></SENT>
<SENT sid="5" pm="."><plain>Aβ(25-35) -treated cardiomyocytes had smaller calcium transient, SR calcium store, L-type calcium current and <z:chebi fb="199" ids="26708">sodium</z:chebi>/calcium exchanger current than control cardiomyocytes </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, Aβ(25-35) -treated cardiomyocytes (n = 20) had shorter 90% of the action potential duration (82 ± 3 vs. 93 ± 5 ms, P &lt; 0·05) than control cardiomyocytes (n = 16) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Aβ(25-35) has direct electrophysiological effects on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> cardiomyocytes </plain></SENT>
</text></document>